UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brain

Acta neuropathologica, 2018-07, Vol.136 (1), p.19-40

2018

Volltextzugriff (PDF)

Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance

Neurobiology of disease, 2016-01, Vol.85, p.111-121

2016

Volltextzugriff (PDF)

Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

Neuron (Cambridge, Mass.), 2014-04, Vol.82 (2), p.308-319

2014

Volltextzugriff (PDF)

An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer's disease

Nature communications, 2018-07, Vol.9 (1), p.2676-13, Article 2676

2018

Volltextzugriff (PDF)

Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain

Brain (London, England : 1878), 2019-05, Vol.142 (5), p.1441-1457

2019

Volltextzugriff (PDF)

The Aggregation Paths and Products of Aβ42 Dimers Are Distinct from Those of the Aβ42 Monomer

Biochemistry (Easton), 2016-11, Vol.55 (44), p.6150-6161

2016

Volltextzugriff (PDF)

Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity

Cell reports (Cambridge), 2018-05, Vol.23 (7), p.1932-1938

2018

Volltextzugriff (PDF)

A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid

Alzheimer's research & therapy, 2015, Vol.7 (1), p.14-14, Article 14

2015

Volltextzugriff (PDF)

Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies

Biochemical journal, 2014-08, Vol.461 (3), p.413-426

2014

Volltextzugriff (PDF)

Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer’s Disease

ACS chemical neuroscience, 2022-12, Vol.13 (24), p.3641-3660

2022

Volltextzugriff (PDF)

The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species

Alzheimer's & dementia, 2015-11, Vol.11 (11), p.1286-1305

2015

Volltextzugriff (PDF)

IgG Conformer's Binding to Amyloidogenic Aggregates

PloS one, 2015-09, Vol.10 (9), p.e0137344-e0137344

2015

Volltextzugriff (PDF)

Production and Use of Recombinant Aβ for Aggregation Studies

Methods in molecular biology (Clifton, N.J.), 2018, Vol.1777, p.307

2018

Volltextzugriff (PDF)

C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death

The Journal of neuroscience, 2015-07, Vol.35 (30), p.10851-10865

2015

Volltextzugriff (PDF)

Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation in Vivo

The Journal of neuroscience, 2023-08, Vol.43 (32), p.5870-5879

2023

Volltextzugriff (PDF)

Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-β Aggregates

Advanced healthcare materials, 2015-10, Vol.4 (14), p.2100-2109

2015

Volltextzugriff (PDF)

Alzheimer's Disease: Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-β Aggregates (Adv. Healthcare Mater. 14/2015)

Advanced healthcare materials, 2015-10, Vol.4 (14), p.2049-2049

2015

Volltextzugriff (PDF)

Diffusible, highly bioactive oligomers represent a critical minority of soluble A[beta] in Alzheimer's disease brain

Acta neuropathologica, 2018-07, Vol.136 (1), p.19

2018

Volltextzugriff (PDF)

The aggregation paths and products of Aβ42 dimers are distinct from Aβ42 monomer

Biochemistry (Easton), 2016-10, Vol.55 (44), p.6150-6161

2016

Volltextzugriff (PDF)

The aqueous phase of Alzheimer's disease brain contains assemblies built from similar to 4 and similar to 7 kDa A beta species

Alzheimer's & dementia, 2015-11, Vol.11 (11), p.1286

2015

Volltextzugriff (PDF)

P4‐058: A Novel Paradigm for the Identification and Targeting of Bioactive Abeta Species from Alzheimer Brain

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_21), p.P1037-P1037

2016

Volltextzugriff (PDF)

MEDI1814, A HIGH-AFFINITY ANTIBODY DIRECTED TO THE C-TERMINUS OF AβX-42, ABROGATES SYNAPTIC PLASTICITY DISRUPTION CAUSED BY SYNTHETIC OR AD BRAIN-DERIVED Aβ SOLUBLE ASSEMBLIES IN VIVO

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P943-P944

2017

Volltextzugriff (PDF)

Soluble A[beta] Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

Neuron (Cambridge, Mass.), 2014-04, Vol.82 (2), p.308

2014

Volltextzugriff (PDF)

Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-[beta] Aggregates

Advanced healthcare materials, 2015-10, Vol.4 (14), p.2100

2015

Volltextzugriff (PDF)

Alzheimer's Disease: Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-[beta] Aggregates

Advanced healthcare materials, 2015-10, Vol.4 (14), p.2049

2015

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brain

Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance

Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer's disease

Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain

The Aggregation Paths and Products of Aβ42 Dimers Are Distinct from Those of the Aβ42 Monomer

Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity

A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid

Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies

Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer’s Disease

The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species

IgG Conformer's Binding to Amyloidogenic Aggregates

Production and Use of Recombinant Aβ for Aggregation Studies

C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death

Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation in Vivo

Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-β Aggregates

Alzheimer's Disease: Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-β Aggregates (Adv. Healthcare Mater. 14/2015)

Diffusible, highly bioactive oligomers represent a critical minority of soluble A[beta] in Alzheimer's disease brain

The aggregation paths and products of Aβ42 dimers are distinct from Aβ42 monomer

The aqueous phase of Alzheimer's disease brain contains assemblies built from similar to 4 and similar to 7 kDa A beta species

P4‐058: A Novel Paradigm for the Identification and Targeting of Bioactive Abeta Species from Alzheimer Brain

MEDI1814, A HIGH-AFFINITY ANTIBODY DIRECTED TO THE C-TERMINUS OF AβX-42, ABROGATES SYNAPTIC PLASTICITY DISRUPTION CAUSED BY SYNTHETIC OR AD BRAIN-DERIVED Aβ SOLUBLE ASSEMBLIES IN VIVO

Soluble A[beta] Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-[beta] Aggregates

Alzheimer's Disease: Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid-[beta] Aggregates

Suchergebnisse filtern